[1] |
LIU Dan, WAN Nansheng, WANG Jie, LI Guangsheng, XIE Wei, TIAN Yu, FENG Jing.
A new diagnosis and ablation technique of lung isolated percutaneous transthoracic needle biopsy
[J]. Tianjin Medical Journal, 2024, 52(9): 982-984.
|
[2] |
HUO Jingchen, WANG Yue, LI Hua, QIU Rong, SU Jingwei, WANG Zhuofan, YANG Jie.
Predictive value of systemic immune inflammation index (SII) on long-term survival of patients with stage III squamous lung cancer treated with radical radiotherapy
[J]. Tianjin Medical Journal, 2024, 52(6): 634-638.
|
[3] |
ZHANG Caidie, JIN Yan, ZHANG Dede.
The anti-tumor effect of Runfei Yishen drink on lung cancer bearing rats and its impact on tumor immune microenvironment
[J]. Tianjin Medical Journal, 2024, 52(4): 362-366.
|
[4] |
QIN Aiying, CHEN Jing, SHAN Fengxiao, LU Hanjie, WU Yang.
The correlation between expression of lncRNA MIR503HG and Wnt1 in non-small cell lung cancer tissue and patient survival within 5 years after surgery
[J]. Tianjin Medical Journal, 2024, 52(4): 403-408.
|
[5] |
XU Dan, LIU Xia, ZHONG Diansheng.
Frst-line treatment of Zorifertinib in EGFR-mutant NSCLC with CNS metastases: a report of two cases
[J]. Tianjin Medical Journal, 2024, 52(3): 315-318.
|
[6] |
JIANG Zhongmin, ZHANG Chunyan, LIU Min, ZHENG Jie, LI Yanxia, REN Qingcuo, MENG Wei, LIU Xiaozhi.
Construction of micropapillary lung adenocarcinoma organoids and screening of targeted drugs
[J]. Tianjin Medical Journal, 2024, 52(1): 22-27.
|
[7] |
MA Xue, WU Jing, ZHANG Hongli, LI Yong, SONG Juan, LI Yuanli, LU Liang, ZHU Haizhen.
Imaging of lung cancer with molecular beacons delivered by octreotide-modified chitosan nanoparticles
[J]. Tianjin Medical Journal, 2024, 52(1): 61-67.
|
[8] |
ZHANG Zhenhua, FU Wei, LIU Weiliang, LI Junyan, HUANG Tao, HU Hui, FAN Zhigang.
Application of PET/CT radiomics combined with LncRNA-DGCR5 in precision medicine of NSCLC
[J]. Tianjin Medical Journal, 2023, 51(9): 1011-1015.
|
[9] |
ZHANG Tianwei, ZHANG Jinbiao, ZHANG Yan, MING Hui, ZHANG Peng, NIE Dong.
Changes and clinical significance of serum circPVT1 and miR-486-5p levels before and after radiotherapy for advanced NSCLC
[J]. Tianjin Medical Journal, 2023, 51(9): 998-1001.
|
[10] |
HUANG Lin, LI Bin, HU Zuowei.
The radiosensitizing effect of ginsenoside Rg3 on lung cancer cells by inhibiting mTOR pathway-mediated pentose phosphate pathway
[J]. Tianjin Medical Journal, 2023, 51(8): 791-796.
|
[11] |
WANG Hongjun, SUN Xingxing, ZHANG Runlian.
Study on the effect of Shengyang Yiwei Decoction on the immune function of rats with lung cancer based on PI3K/Akt/NF-κB signal pathway
[J]. Tianjin Medical Journal, 2023, 51(7): 739-745.
|
[12] |
DU Wenfeng, ZHOU Ling, LI Qi.
Effects of CircCDR1as on the biological behavior of NSCLC cells by regulating the miR-671-5p/CBX4 axis
[J]. Tianjin Medical Journal, 2023, 51(6): 573-579.
|
[13] |
WU Keyi, HUANG Yong, XU Chenghao, MA Tianming, DAI Feibiao, LI Xue, TANG Chaoliang.
Effects of general anesthesia combined with thoracic paravertebral nerve block on postoperative analgesia and pulmonary infection in patients with lung cancer surgery
[J]. Tianjin Medical Journal, 2023, 51(6): 648-652.
|
[14] |
HUANG Yugang, TAN Lingjuan, CHEN Guang.
Effects of lupeol on the biological behavior of non-small cell lung cancer NCI-H1299 cells by regulating miR-100-5p
[J]. Tianjin Medical Journal, 2023, 51(2): 118-123.
|
[15] |
XU Jinhui, XU Guangjuan, DUAN Lufen, LIU Kaili, ZHOU Qin, SUN Jiantong, DING Xinyuan.
The risk factor analysis for immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors and their relationship to effectiveness
[J]. Tianjin Medical Journal, 2023, 51(2): 207-212.
|